Physician profile
Dean E Bright
NPI 1770581357
$175,166.80
in general payments reported to CMS, 2019-2025
27 companies · $23K in 2025
The $23K reported for 2025 was more than what 98% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,654 · 2020: $5,606 · 2021: $7,916 · 2022: $29K · 2023: $81K · 2024: $23K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $103K · Travel and Lodging: $18K · Food and Beverage: $4,099 · Royalty Or License: $2,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $103,050.00 |
| Travel and Lodging | $18,322.49 |
| Food and Beverage | $4,098.85 |
| Royalty Or License | $2,170.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $152,903.89 | 2019-2025 | |
| Trilliant Surgical LLC. | $9,640.86 | 2020-2021 | |
| Fusion Orthopedics USA, LLC | $5,892.52 | 2023-2025 | Universal Mtp Plates, Midfoot Universal, Universal Mtp Plate |
| Arthrosurface Incorporated | $1,707.20 | 2019 | |
| Paragon 28, INC. | $1,410.36 | 2019 | |
| In2bones USA, LLC | $1,200.00 | 2021 | |
| Fusion Orthopedics, LLC. | $1,022.67 | 2021-2024 | Polylock Midfoot, Midfoot Universal |
| Abbott Laboratories | $386.69 | 2021-2024 | Proclaim |
| Stryker Corporation | $229.32 | 2019-2020 | |
| Nevro Corp. | $204.56 | 2022-2023 | Senza |
| Organogenesis INC. | $103.09 | 2023-2025 | Puraply, Via Matrix |
| Amgen INC. | $58.13 | 2025 | Krystexxa |
| Pacira Pharmaceuticals Incorporated | $49.67 | 2024-2025 | Exparel, Iovera |
| Baudax Bio INC. | $46.95 | 2022 | |
| Depuy Synthes Sales INC. | $41.96 | 2025 | Motoband |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $38.93 | 2019 | |
| Medtronic, INC. | $32.01 | 2025 | Inceptiv |
| Midsouth Orthopedics INC. | $31.55 | 2022-2024 | |
| Smith+Nephew, INC. | $27.75 | 2021 | |
| Djo, LLC | $21.76 | 2024 | Cmf |
| Horizon Therapeutics Plc | $20.11 | 2022 | |
| Ani Pharmaceuticals, INC. | $19.74 | 2025 | Purified Cortrophin Gel |
| Encore Medical, Lp | $19.10 | 2021 | |
| Convatec INC. | $16.18 | 2023 | |
| Kerecis Limited | $14.85 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Akorn, INC. | $13.98 | 2020 | |
| Merck Sharp & Dohme LLC | $12.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Bright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.